Table 1 Relationships of LASS2 expression level with the clinicopathological features in liver cancer patients (n = 90).

From: LASS2 enhances p53 protein stability and nuclear import to suppress liver cancer progression through interaction with MDM2/MDMX

Characteristics

Lass2 ID Score

P

0-4

6-12

Sex

  

0.086

 Male

49

19

 

 Female

20

2

 

Age (years)

  

0.798

 ≤50

27

7

 

 >50

42

14

 

Tumor size

  

0.029*

 ≤30 mm

4

5

 

 >30 mm

65

16

 

TNM Stage

  

0.013*

 I

9

8

 

 II

37

11

 

 III–IV

23

2

 

AFP

  

0.803

 ≤20 ng/ml

43

11

 

 >20 ng/ml

26

10

 

Acetyl-p53(Lys-373)

  

0.033*

 Low expression

51

10

 

 High expression

18

11

 
  1. *P < 0.05.
Back to article page